Pre-order Enquiry
Download Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Saflufenacil is an herbicide of the pyrimidinedione chemical class used to control annual broadleaf weeds in soybeans and corn. It was developed by BASF and is marketed under the Kixor trademark. Saflufenacil works by inhibiting protoporphyrinogen IX oxidase (PPO), resulting in plant accumulation of protoporphyrin IX (proto) and H2O2; inhibiting PPO formation results in prevention of chlorophyll, heme, and cytochrome synthesis; also, proto accumulation causes lipid peroxidation, resulting in rapid loss of membrane integrity and function; only slight increases of proto and H2O2 occur in corn.
The Saflufenacil market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Saflufenacil market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Saflufenacil market.
Major Players in the Saflufenacil market are:
Sigma-Aldrich
Bryant Christie Inc.
BASF Corporation
PGG Wrightson
AccuStandard
Chem Service Inc.
On the basis of types, the Saflufenacil market is primarily split into:
BAS 800 H
Others
On the basis of applications, the market covers:
Soybeans
Corns
Others
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
2021
The Saflufenacil market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Saflufenacil market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Saflufenacil market.
Major Players in the Saflufenacil market are:
Sigma-Aldrich
Bryant Christie Inc.
BASF Corporation
PGG Wrightson
AccuStandard
Chem Service Inc.
On the basis of types, the Saflufenacil market is primarily split into:
BAS 800 H
Others
On the basis of applications, the market covers:
Soybeans
Corns
Others
Major Region
s or countries covered in this report:United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years:
2017-2021Base Year:
2021Estimated Year:
2022Forecast Period:
2022-2029Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
